Back to Selection     Print       Date : 31 Oct 2025
Fund Summary
Bandhan Focused Fund Reg (G)
[Equity: Focused]  
 
Fund Details
Fund Type Growth Launch Date 16-Mar-06
Corpus(Cr.) 2086.0 Latest NAV 88.992 As on 05-12-2025
Equity(%) 98.41 52 Week High 91.785
Debt(%) 1.59 52 Week Low 75.133
Others(%) 0.0 Exit Load For units in excess of 10% of the investment, 1% will be charged for redemption within 365 days
Minimum Investment - Availability
Entry Load Nil Expense Ratio(%) 2.05
Scheme Benchmark BSE 500 TRI Broader Benchmark NSE - Nifty 50 TRI
Fund Manager Kirthi Jain
 
Riskometer
Investors understand that their principal will be at Very High risk
 
Scheme Objective
The scheme aims to generate capital appreciation by investing in a concentrated portfolio of equity & equity related instruments of upto 30 stocks.

Portfolio Classification
 
Asset Mix
 
Concentration Analysis
Top 5 Holdings 30.22%
Top 10 Holdings 50.89%
Top 25 Holdings 92.14%
 
Sector Analysis
Sector/Ratings Net Asset(%)
Banking & Financial 21.8
Pharma & Biotech 14.94
Finance & Investments 11.78
Retail 9.52
Food Beverage & Tobacco 6.76
Software & Services 5.98
Agricultural & Farm Machinery 5.57
Technology 3.81
Construction 3.69
Chemicals 3.06
FMCG 2.88
Petroleum Products 2.54
Telecom 2.26
Energy 2.01
Textiles 1.81
Cash 1.59
 
 
 
 
 
Portfolio Metrics
PB Ratio 2.76
PE Ratio 18.09
 
Top 25 Holdings
Holdings Net Asset(%)
POWER FINANCE CORPORATION LTD 7.91
HDFC Bank Limited 6.16
State Bank Of India 6.00
LT Foods Limited 5.57
ICICI Bank Limited 4.58
Prestige Estates Projects Limited 4.39
Tilaknagar Industries Limited 4.21
Jubilant Pharmova Limited 4.19
Glenmark Pharmaceuticals Limited 4.01
CHOLAMANDALAM FIN HOL LTD 3.87
One 97 Communications Limited 3.81
Larsen & Toubro Limited 3.69
SOUTH INDIAN BANK LTD 3.45
Infosys Limited 3.13
Deepak Fertilisers & Petrochemicals Corp. Ltd. 3.06
ITC Limited 2.88
SIGNATURE GLOBAL (INDIA) LIMITED 2.68
Varun Beverages Limited 2.55
Reliance Industries Limited 2.54
Eternal Limited 2.45
Aurobindo Pharma Limited 2.41
J B Chemicals and Pharma Ltd 2.27
Bharti Airtel Limited 2.26
Mankind Pharma Limited 2.06
NTPC Limited 2.01

Performance Analysis
 
Short Terms Returns
1 Month 3 Month 6 Month 1 Year
-0.24% 3.70% 1.85% -2.43%
 
Broader Market Benchmark [NSE - Nifty 50 TRI]
2.70% 6.00% 5.46% 7.43%
 
Scheme Benchmark [NSE - Nifty 500 TRI]
1.42% 4.55% 3.51% 3.28%
 
Long term Returns
2 Year 3 Year 5 Year 10 Year
16.47% 18.21% 15.45% 13.41%
 
 
13.19% 13.29% 15.94% 14.28%
 
 
14.06% 15.48% 17.95% 14.98%
 
Cumulative Performance of Last 5 Years
 
Calendar Year Returns

Risk Analysis
 
Absolute Metrics (Single Computation - last 3 years)
Scheme Name Standard Deviation Sharpe Ratio Downside Deviation Downside Probability Sortino Ratio
Bandhan Focused Fund Reg (G) 14.03% 0.7613 11.3138% 43.0872 0.1154
 
Benchmark Relative Metrics (Single Computation - last 3 years)
Scheme Name Alpha Beta Treynor Ratio Tracking Error Information Ratio
Bandhan Focused Fund Reg (G) 5.7209% 0.0004 0.1301 8.6510 0.8159
 
Back to Selection